ZYDUSWELLBSEZydus Wellness Ltd-$LowNeutral
Announced Fri, 22 May · 11:44 IST

Transcript of the Earnings conference call held on May 18, 2026

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

ZYDUSWELL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.6%1-day move
₹495.60
prior close
₹491.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.1+0.1+0.1-1.6-2.4-3.0+1.8+0.5+2.0+0.5+9.0+15.0
Up moveDown movePending
AI summary

Zydus Wellness reported Q4 FY2026 net sales growth of 62.1%, driven by strong international business including Comfort Click delivering 31.4% like-to-like growth while domestic grew only 1.7%. Seasonal brands declined 9.8% due to delayed summer and unseasonal rains in March-April, primarily impacting North and East regions. EBITDA grew 42.2% to INR 2,701 million for the quarter, and full year EBITDA reached INR 5,097 million (34.2% growth). Net profit declined 5.8% in Q4 due to higher finance costs from the Comfort Click acquisition loan and increased amortization of acquired brands; however, net profit excluding exceptional items and amortization grew 17% in Q4. Comfort Click is already EPS-accretive in Q4, seven months post-acquisition, with management confirming it is on track with the earlier guided ~14-15% EBITDA margin. Multiple new product launches were highlighted across RiteBite Max Protein, Sugar Free D'lite, Everyuth, Glucon-D Recharge, and WeightWorld/Animigo, with AI-led consumer targeting being leveraged.

Likely market impact

The company remains on a growth trajectory with a larger revenue base (near INR 4,000 crore) but faces near-term margin pressure from seasonal brand underperformance and acquisition-related costs. Management remains confident about operating leverage playing out to reach 17-18% EBITDA margin aspirational target over time.